Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR210HG (MIR210 host gene) is a long non-coding RNA (lncRNA) gene that encodes a transcript hosting the microRNA miR-210 within its intronic sequence[5]. MIR210HG itself does not code for a protein but is considered important for the expression and regulation of miR-210, especially under hypoxic conditions. While the precise biological role of the MIR210HG lncRNA beyond hosting miR-210 remains under investigation, it has been associated with diseases such as osteogenic sarcoma, hepatoblastoma, and varicocele[5]. The functional significance of this lncRNA in cancer and its regulatory interactions with miR-210 suggest it may have roles in tumor biology, but it is not itself considered a classic therapeutic target such as a receptor, enzyme, or transporter.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR210 host gene (non-protein coding) (MIR210HG).